chr10:43077068:> Detail (hg38) (RET)

Information

Genome

Assembly Position
hg19 chr10:43,572,516-43,625,799 
hg38 chr10:43,077,068-43,130,351

HGVS

Type Transcript Protein
Summary

MGeND

Clinical significance
Variant entry
GWAS entry
Disease area statistics Show details

Frequency

[No Data.]

Prediction

[No Data.]

ClinVar

Clinical Significance
Review star [No Data.]
Show details
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
Disease Drug EL ET ED CS VO TR Pubmed Links
lung non-small cell carcinoma Cabozantinib B Predictive Supports Sensitivity/Response Somatic 3 27825636 Detail
lung non-small cell carcinoma Vandetanib B Predictive Supports Sensitivity/Response Somatic 3 27803005 Detail
lung non-small cell carcinoma Vandetanib B Predictive Supports Sensitivity/Response Somatic 3 27825616 Detail
lung non-small cell carcinoma Alectinib B Predictive Supports Sensitivity/Response Somatic 3 27544060 Detail
DisGeNET
[No Data.]
Annotation

Annotations

DescrptionSourceLinks
RET rearrangements are found in 1-2% of non-small-cell lung cancers. Cabozantinib is a multikinase i... CIViC Evidence Detail
RET rearrangements involving RET are found in about 1% of NSCLC and define a unique molecular subset... CIViC Evidence Detail
We aimed to assess the efficacy and safety of vandetanib in patients with advanced RET-rearranged NS... CIViC Evidence Detail
Alectinib is an anaplastic lymphoma kinase tyrosine kinase inhibitor (TKI) that also has anti-RET ac... CIViC Evidence Detail

Overlapped Transcript Coordinates

Gene Transcript ID Exon Number Chromosome Start Stop Type Amino Mutation Transcript Position Links

Overlapped Transcript

Gene Transcript ID Chromosome Start Stop Links
Gene
-
Genome
hg38
Position
chr10:43,077,068-43,130,351
Variant Type
snv
Variant (CIViC) (CIViC Variant)
FUSION
Variant URL (CIViC Variant)
https://civic.genome.wustl.edu/links/variants/1687
Genome browser